Product Detail

Current Location: Home> Industry Enzymes>CRISPR-Cas Proteins>EB0502 LbCas12a
EB0502 LbCas12a

Synonym: EB0502 LbCas12a

Species: Lachnospiraceae bacterium

Protein Accession: QKH13994

Purity: 95%

Endotoxin Level: <1 EU/μg

Biological Activity: N/A

Expression System: Escherichia coli

Fusion Tag: N/A

Predicted Molecular Mass: 162 kDa

Formulation: Supplied as a lyophilized powder

Reconstitution: Reconstitute in PBS, pH 7.4 to a concentration of 0.1-1.0 mg/ml

Storage & Stability: Store lyophilized protein at -20°C. Reconstituted protein can be stored at 4°C for a few days or at -20°C for longer periods. Avoid repeated freeze/thaw cycles.

FAQ

What is EB0502 LbCas12a and how does it work in the feed industry?

EB0502 LbCas12a is a CRISPR-associated enzyme derived from the bacterium Lachnospiraceae bacterium ND2006. It is a robust genome-editing tool that has been adapted for various applications in the feed industry. The enzyme works by targeting specific DNA sequences and inducing double-stranded breaks at precise locations within the genome. This targeted cleavage facilitates the introduction of genetic modifications, allowing for the enhancement of desirable traits in livestock or the development of novel feed ingredients. In the feed industry, EB0502 LbCas12a can be employed to increase the nutritional value of feed, improve the health and productivity of livestock, and reduce reliance on antibiotics and other chemical additives. Its high specificity and efficiency make it a valuable tool for advancing agricultural biotechnology and ensuring a more sustainable and efficient food production system.

What are the benefits of using EB0502 LbCas12a in animal feed production?

The use of EB0502 LbCas12a in animal feed production offers several significant benefits. By enabling precise genetic modifications, it allows for the development of feed that is more nutritionally balanced, which can enhance the growth rates and overall health of livestock. Additionally, it can be used to create feed ingredients that are more easily digestible, thereby improving feed conversion ratios and reducing waste. This technology also offers the potential to develop livestock with enhanced disease resistance, which can lead to reduced dependency on antibiotics and other veterinary drugs. Furthermore, EB0502 LbCas12a supports the creation of environmentally sustainable feed solutions by facilitating the development of crops that require fewer resources to grow, contributing to lower greenhouse gas emissions and less environmental degradation. These benefits collectively promote a more sustainable, efficient, and productive agricultural system.

How does EB0502 LbCas12a compare to other genome-editing technologies currently used in the feed industry?

EB0502 LbCas12a stands out among genome-editing technologies due to its unique characteristics and advantages. Unlike other commonly used tools such as CRISPR/Cas9, LbCas12a recognizes and binds to different protospacer adjacent motif (PAM) sequences, which broadens the range of potential target sites within a genome. This versatility enhances its precision in making genetic modifications. Additionally, EB0502 LbCas12a cuts DNA in a staggered fashion, producing sticky ends rather than blunt ends, which facilitates more efficient and accurate insertion of desired genetic material. The enzyme's high specificity reduces the risk of off-target effects, making it safer for use in modifying genes associated with complex traits in animals or feed crops. It also offers advantages in multiplexing, allowing for the simultaneous editing of multiple genes within a single organism. These features make EB0502 LbCas12a a highly effective and versatile tool for advancing genetic improvement programs in the feed industry.

What ethical considerations are associated with the use of EB0502 LbCas12a in the feed industry?

The use of EB0502 LbCas12a in the feed industry raises several ethical considerations that need to be addressed. One major concern is the welfare of the genetically modified animals, such as ensuring that the modifications do not cause unintended harm or suffering. There is also the broader issue of environmental impact, where rigorous risk assessments must be conducted to evaluate the potential effects of releasing genetically modified organisms into the ecosystem. The ethical implications of gene editing on biodiversity and ecosystem balance must be carefully considered. Additionally, there are societal and cultural concerns related to the acceptance of genetically modified organisms (GMOs) in food production. Public perception and consumer trust are critical, so transparency about the use of such technologies and their benefits and risks is essential. Finally, there is the need for regulatory frameworks that ensure the responsible and ethical use of genome-editing technologies, ensuring that they are employed safely and equitably in the pursuit of agricultural and environmental sustainability.

Can EB0502 LbCas12a be used to enhance the nutritional content of feed ingredients?

Yes, EB0502 LbCas12a can be utilised to enhance the nutritional content of feed ingredients significantly. By enabling precise modifications to the genetic makeup of feed crops, this technology can result in the development of plants that have increased levels of essential nutrients such as proteins, vitamins, and minerals. For instance, genes responsible for the synthesis of amino acids or micronutrients can be upregulated, leading to crops with higher nutritional value. Additionally, antisense RNA or other gene silencing techniques can be employed to reduce the levels of anti-nutritional factors in feed ingredients, thereby improving their digestibility and nutritional quality. These genetic enhancements can lead to the production of more nutritionally balanced feed, which can support better growth, health, and productivity in livestock. By addressing specific nutritional deficiencies in animal diets, EB0502 LbCas12a contributes to the development of tailored feed solutions that meet the precise nutritional needs of various livestock species.

Jiangsu East-Mab Biomedical Technology Co.,Ltd

contact us

Factory address:
Life and Health Industrial Park, Rudong County, Nantong City, Jiangsu Province

Contact: Fred Wang
Tel: 0086-25-52397805
Phone/WhatsApp: 0086-18005193850

mobile
Jiangsu East-Mab Biomedical Technology Co.,Ltd

Copyright(C)2023,Jiangsu East-Mab Biomedical Technology Co.,Ltd All Rights Reserved.

Leave A Message
Leave A Message ×
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.